BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35156249)

  • 1. Immunotherapy for the treatment of perineural spread in cutaneous head and neck squamous cell carcinoma: Time to rethink treatment paradigms.
    Nightingale J; Gandhi M; Helena J; Bowman J; McGrath M; Coward J; Porceddu S; Ladwa R; Panizza B
    Head Neck; 2022 May; 44(5):1099-1105. PubMed ID: 35156249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Perineural Invasion and Immunotherapy for Head and Neck Cutaneous Squamous Cell Carcinoma.
    Wu MP; Reinshagen KL; Cunnane MB; Shalhout SZ; Kaufman HL; Miller D; Emerick KS
    Laryngoscope; 2022 Jun; 132(6):1213-1218. PubMed ID: 34797598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of perineural spread in advanced cutaneous squamous cell carcinomas treated with immunotherapy.
    Cavanagh K; McLean LS; Lim AM; Cardin A; Levy SM; Rischin D
    Cancer Imaging; 2024 Mar; 24(1):37. PubMed ID: 38500235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persisting facial nerve palsy or trigeminal neuralgia - red flags for perineural spread of head and neck cutaneous squamous cell carcinoma (HNcSCC).
    Zhang M; Phung D; Gupta R; Wykes J; Wu R; Lee J; Elliott M; Palme CE; Clark J; Low TH
    ANZ J Surg; 2023 Oct; 93(10):2394-2401. PubMed ID: 37485776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy response in patients with cutaneous squamous cell carcinoma of head and neck with cranial nerve involvement.
    Lopetegui-Lia N; Dima D; Buchberger DS; Yalamanchali A; Osantowski B; Ondeck M; Lorenz RR; Prendes B; Ku J; Lamarre E; Scharpf J; Silver NL; Schwartzman L; Geiger JL; Woody NM; Campbell SR; Koyfman SA; Yilmaz E
    Head Neck; 2023 Aug; 45(8):2149-2154. PubMed ID: 37272705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Review.
    Desai N; Divatia MK; Jadhav A; Wagh A
    Curr Oncol; 2023 Jul; 30(7):6634-6647. PubMed ID: 37504347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of diffusion-weighted MR imaging and
    Schroeder C; Lee JH; Tetzner U; Seidel S; Kim SY
    Eur J Radiol; 2020 Sep; 130():109157. PubMed ID: 32652403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Durable tumor regression and restoration of neurologic function after treatment with anti-PD-1 in patients with functionally unresectable cutaneous squamous cell carcinoma with perineural spread into the cavernous sinus.
    Carey AR; Warrier G; Hoang JK; Schollenberger MD; Lipson EJ; Mahoney NR
    J Neurooncol; 2023 Sep; 164(2):431-436. PubMed ID: 37656376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival outcomes of perineural spread in head and neck cutaneous squamous cell carcinoma.
    Phung D; Ahmadi N; Gupta R; Clark JR; Wykes J; Ch'ng S; Elliott MS; Palme CE; Shannon K; Wu R; Lee JH; Low TH
    ANZ J Surg; 2022 Sep; 92(9):2299-2304. PubMed ID: 35866314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California.
    In GK; Vaidya P; Filkins A; Hermel DJ; King KG; Ragab O; Tseng WW; Swanson M; Kokot N; Lang JE; Menendez L; DeClerck B; Kim G; Hu JC; Terando A; Jadvar H; Ricker C; Miller KA; Peng DH; Wysong A
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1803-1811. PubMed ID: 33210210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into the epidemiology of cutaneous squamous cell carcinoma with perineural spread.
    Warren TA; Whiteman DC; Porceddu SV; Panizza BJ
    Head Neck; 2016 Sep; 38(9):1416-20. PubMed ID: 27043827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic value of 18F-FDG PET, CT, and MRI in perineural spread of head and neck malignancies.
    Dercle L; Hartl D; Rozenblum-Beddok L; Mokrane FZ; Seban RD; Yeh R; Bidault F; Ammari S
    Eur Radiol; 2018 Apr; 28(4):1761-1770. PubMed ID: 29086023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facial nerve perineural spread from cutaneous squamous cell carcinoma of the head and neck: A single institution analysis of epidemiology, treatment, survival outcomes, and prognostic factors.
    Schachtel MJC; Gandhi M; Bowman JJ; Porceddu SV; Panizza BJ
    Head Neck; 2022 May; 44(5):1223-1236. PubMed ID: 35224794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
    Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
    Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal imaging analysis of an orthotopic head and neck cancer mouse model and application of anti-CD137 tumor immune therapy.
    Vahle AK; Hermann S; Schäfers M; Wildner M; Kerem A; Öztürk E; Jure-Kunkel M; Franklin C; Lang S; Brandau S
    Head Neck; 2016 Apr; 38(4):542-9. PubMed ID: 25482887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case report: Patient specific combination of surgery and immunotherapy in advanced squamous cell carcinoma of the head and neck - a case series and review of literature.
    Olmos M; Lutz R; Büntemeyer TO; Glajzer J; Nobis CP; Ries J; Möst T; Eckstein M; Hecht M; Gostian AO; Erdmann M; Foerster Y; Kesting M; Weber M
    Front Immunol; 2022; 13():970823. PubMed ID: 36389668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
    Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
    Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of checkpoint inhibition on head and neck squamous cell carcinoma: A systematic review.
    Ghanizada M; Jakobsen KK; Grønhøj C; von Buchwald C
    Oral Oncol; 2019 Mar; 90():67-73. PubMed ID: 30846179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-look PET-CT following an initial incomplete PET-CT response to (chemo)radiotherapy for head and neck squamous cell carcinoma.
    Prestwich RJD; Arunsingh M; Zhong J; Dyker KE; Vaidyanathan S; Scarsbrook AF
    Eur Radiol; 2020 Feb; 30(2):1212-1220. PubMed ID: 31485835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
    Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
    Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.